Evidence map›Paper›PMID 24324260›Full record

ArticleThe Journal of biological chemistry2014

Overexpression of c-Met and CD44v6 receptors contributes to autocrine TGF-β1 signaling in interstitial lung disease.

Shibnath Ghatak, Galina S Bogatkevich, Ilia Atnelishvili, Tanjina Akter, Carol Feghali-Bostwick, Stanley Hoffman, Victor M Fresco, John C Fuchs, Richard P Visconti, Roger R Markwald and 4 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.0field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. The MET Oncogene Network of Interacting Cell Surface Proteins.International journal of molecular sciences · 2024
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 3 countries.

Shibnath GhatakFrom the Department of Regenerative Medicine and Cell Biology and.
Galina S Bogatkevich
Ilia Atnelishvili
Tanjina Akter
Carol Feghali-Bostwick
Stanley Hoffman
Victor M Fresco
John C Fuchs
Richard P Visconti
Roger R Markwald
Subhas B Padhye
Richard M Silver
Vincent C Hascall
Suniti Misra
Medical University of South Carolina · USCenter for Rheumatology · USRegenerative Medicine Institute · MXCleveland Clinic · USNational Defence Academy · IN

Funding

Supplement for South Carolina BRIN - 1P20 RR16461P20RR016461 · NCRR · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI DEAVOR, JAMES · 2001 to 2011
$32.3M
UBIQUITIN CARBOXYL TERMINAL HYDROLASE L1 (UCH-L1) AND VASCULAR LESION FORMATIONP20RR016434 · NCRR · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI MARKWALD, ROGER R · 2001 to 2011
$24.8M
VERSICAN PROTEOLYSIS AND REGULATION OF VASCULAR SMOOTH MUSCLEP01HL107147 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI LAUER, MARK E · 2011 to 2017
$16.1M
South Carolina Clinical & Translational Research Institute (SCTR)UL1TR000062 · NCATS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BRADY, KATHLEEN T. · 2012 to 2014
$9.4M
UNDERSTANDING AND CONTROLLING TISSUE-SPECIFIC VASCULAR PATTERNINGP20RR021949 · NCRR · CLEMSON UNIVERSITY · PI MARKWALD, ROGER R · 2009 to 2011
$5.2M
MUCOPOLYSACCHRIDE METABOLISM IN CARDIAC ANOMALIESR01HL033756 · NHLBI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI MARKWALD, ROGER R · 1985 to 2015
$4.8M
Robotics CoreP30AR050953 · NIAMS · CLEVELAND CLINIC LERNER COM-CWRU · PI HASCALL, VINCENT CHARLES · 2004 to 2008
$2.9M
South Carolina Clinical & Translational Research Institute (SCTR)TL1TR000061 · NCATS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BRADY, KATHLEEN T. · 2012 to 2014
$483k
Silencing CD44v6 Expression Prevents Intestinal Tumor GrowthR03CA167722 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI MISRA, SUNITI · 2013 to 2014
$147k
NCATS NIH HHS TL1 TR000061NCATS NIH HHS UL1 TR000062NCI NIH HHS 1R03CA167722-01A1NCI NIH HHS R03 CA167722NCRR NIH HHS P20 RR016434NCRR NIH HHS P20RR016434NCRR NIH HHS P20 RR016461NCRR NIH HHS P20 RR021949NCRR NIH HHS P20RR021949NCRR NIH HHS P20RR16461NHLBI NIH HHS P01 HL107147NHLBI NIH HHS P01HL107147NHLBI NIH HHS R01 HL033756NHLBI NIH HHS R01-HL033756-24NIAMS NIH HHS 1P30AR050953NIAMS NIH HHS P30 AR050953
6 · The paper itself

Abstract

The hepatocyte growth factor (HGF) and the HGF receptor Met pathway are important in the pathogenesis of interstitial lung disease (ILD). Alternatively spliced isoforms of CD44 containing variable exon 6 (CD44v6) and its ligand hyaluronan (HA) alter cellular function in response to interaction between CD44v6 and HGF. TGF-β1 is the crucial cytokine that induces fibrotic action in ILD fibroblasts (ILDFbs). We have identified an autocrine TGF-β1 signaling that up-regulates both Met and CD44v6 mRNA and protein expression. Western blot analysis, flow cytometry, and immunostaining revealed that CD44v6 and Met colocalize in fibroblasts and in tissue sections from ILD patients and in lungs of bleomycin-treated mice. Interestingly, cell proliferation induced by TGF-β1 is mediated through Met and CD44v6. Further, cell proliferation mediated by TGF-β1/CD44v6 is ERK-dependent. In contrast, action of Met on ILDFb proliferation does not require ERK but does require p38(MAPK). ILDFbs were sorted into CD44v6(+)/Met(+) and CD44v6(-)/Met(+) subpopulations. HGF inhibited TGF-β1-stimulated collagen-1 and α-smooth muscle cell actin expression in both of these subpopulations by interfering with TGF-β1 signaling. HGF alone markedly stimulated CD44v6 expression, which in turn regulated collagen-1 synthesis. Our data with primary lung fibroblast cultures with respect to collagen-1, CD44v6, and Met expressions were supported by immunostaining of lung sections from bleomycin-treated mice and from ILD patients. These results define the relationships between CD44v6, Met, and autocrine TGF-β1 signaling and the potential modulating influence of HGF on TGF-β1-induced CD44v6-dependent fibroblast function in ILD fibrosis.

Indexed as

Signal TransductionAnimalsAutocrine CommunicationCell NucleusCell ProliferationCells, CulturedCulture MediaEnzyme-Linked Immunosorbent AssayFemaleFibroblastsFlow CytometryGene Expression RegulationHepatocyte Growth FactorHumansHyaluronan ReceptorsLungCD44v6 antigenCulture MediaHepatocyte Growth FactorHyaluronan ReceptorsProto-Oncogene Proteins c-metRNA, MessengerTransforming Growth Factor beta1Cd44CollagenFibroblastPulmonary FibrosisTransforming Growth Factor beta (TGFbeta)

Identifiers

PMID24324260
PMCPMC3953297
OpenAlexW2010979861

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.